Warnungen, Rückrufe und Sicherheitsinformationen
Diese Sicherheitsinformationen werden bereitgestellt von der Medicines and Healthcare products Regulatory Agency (MHRA), the UK regulator for medicines and medical devices. These alerts may cover medicines, vaccines or medical devices, and can include new safety warnings, prescribing advice, product recalls or field safety notices. They are issued to protect patients and to help healthcare professionals provide safe, effective care.
Patient.info republishes these updates so that both professionals and the public can access the latest official safety communications in one place.
Botulinum toxin type A products: updated warnings regarding risk of iatrogenic botulism
von der Arzneimittel- und Gesundheitsprodukte-Regulierungsbehörde (MHRA)
Field Safety Notices: 6 to 10 July 2026
von der Arzneimittel- und Gesundheitsprodukte-Regulierungsbehörde (MHRA)
A%2F34/og.png)
Class 2 Medicines Recall: Beckton Dickson UK Ltd, ChloraPrep 1mL applicator, EL(26)A/34
von der Arzneimittel- und Gesundheitsprodukte-Regulierungsbehörde (MHRA)
A%2F33/og.png)
Class 2 Medicines Recall: Bristol Laboratories Limited, Phenoxymethylpenicillin 250 mg/5ml Sugar free Oral Solution BP, EL(26)A/33
von der Arzneimittel- und Gesundheitsprodukte-Regulierungsbehörde (MHRA)
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Field Safety Notices: 20 to 24 July 2026List of Field Safety Notices from 20 to 24 July 2026. Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vacci...
By Medicines and Healthcare products Regulatory Agency (MHRA)
A%2F36/rgba(188%2C%2049%2C%20123%2C%201)/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Klasse 4 Arzneimittel-Mängelmeldung: Neuraxpharm UK Ltd, Tuzulby Retard-Kautabletten, EL(26)A/36Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged release 20mg, 30mg an...
By Medicines and Healthcare products Regulatory Agency (MHRA)
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertensionThe product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), due to the risk of epi...
By Medicines and Healthcare products Regulatory Agency (MHRA)
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Sicherheitsmitteilungen: 13. bis 17. Juli 2026List of Field Safety Notices from 13 to 17 July 2026. Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vacci...
By Medicines and Healthcare products Regulatory Agency (MHRA)
A%2F35/rgba(188%2C%2049%2C%20123%2C%201)/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Klasse 4 Arzneimittel-Mängelmeldung: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Retardtabletten, EL(26)A/35Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect tablet counts in the...
By Medicines and Healthcare products Regulatory Agency (MHRA)
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Botulinum toxin type A products: updated warnings regarding risk of iatrogenic botulismCases of iatrogenic botulism have been reported following the therapeutic or cosmetic use of botulinum toxin containing products where the toxin’s effect extends beyond the area of treatment. Patients should seek immedia...
By Medicines and Healthcare products Regulatory Agency (MHRA)
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Field Safety Notices: 6 to 10 July 2026List of Field Safety Notices from 6 to 10 July 2026. Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vaccin...
By Medicines and Healthcare products Regulatory Agency (MHRA)
A%2F34/rgba(188%2C%2049%2C%20123%2C%201)/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Class 2 Medicines Recall: Beckton Dickson UK Ltd, ChloraPrep 1mL applicator, EL(26)A/34Becton Dickinson UK Ltd are recalling batches of ChloraPrep 2% w/v / 70% v/v cutaneous solution 1mL applicators due to a potential breach of sterility in the packaging process. Read the full update from MHRA About MHRA a...
By Medicines and Healthcare products Regulatory Agency (MHRA)
A%2F33/rgba(188%2C%2049%2C%20123%2C%201)/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Class 2 Medicines Recall: Bristol Laboratories Limited, Phenoxymethylpenicillin 250 mg/5ml Sugar free Oral Solution BP, EL(26)A/33Bristol Laboratories Limited is recalling one batch (7124002) of Phenoxymethylpenicillin 250 mg/5 ml Oral Solution Sugar Free due to product labelling issues. Read the full update from MHRA About MHRA alerts and recalls...
By Medicines and Healthcare products Regulatory Agency (MHRA)
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Feldsicherheitsmitteilungen: 29. Juni bis 03. Juli 2026List of Field Safety Notices from 29 June to 03 July 2026 Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, v...
By Medicines and Healthcare products Regulatory Agency (MHRA)
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Feldsicherheitsmitteilungen: 22. bis 26. Juni 2026List of Field Safety Notices from 22 to 26 June 2026. Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vacci...
By Medicines and Healthcare products Regulatory Agency (MHRA)
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Sicherheitsmitteilungen: 22. bis 26. Mai 2026List of Field Safety Notices from 22 to 26 May 2026. Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vaccin...
By Medicines and Healthcare products Regulatory Agency (MHRA)
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
MHRA Sicherheitsrückblick: Juni 2026Summary of the latest safety advice for medicines and medical device users Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator...
By Medicines and Healthcare products Regulatory Agency (MHRA)
A%2F32/rgba(188%2C%2049%2C%20123%2C%201)/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Rückruf von Arzneimitteln der Klasse 3: Flamingo Pharma UK Ltd, Flucloxacillin Kapseln BP 500mg, EL(26)A/32Flamingo Pharma UK Ltd have informed the MHRA that certain packs of Flucloxacillin Capsules BP 500mg contain the incorrect PIL. The affected packs contain the PIL for Amoxicillin 500mg Capsules instead of the PIL for Flu...
By Medicines and Healthcare products Regulatory Agency (MHRA)
A%2F31/rgba(188%2C%2049%2C%20123%2C%201)/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Klasse 4 Arzneimittel-Mängelmeldung: Relonchem Limited, Gabapentin Relonchem 50mg/ml Lösung zum Einnehmen, EL(26)A/31Relonchem Limited have informed the MHRA that particles have been observed inside some bottles of Gabapentin Relonchem Oral Solution, identified through a customer complaint. Read the full update from MHRA About MHRA ale...
By Medicines and Healthcare products Regulatory Agency (MHRA)
A%2F30/rgba(188%2C%2049%2C%20123%2C%201)/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Klasse 4 Arzneimittel-Mängelmeldung: Brancaster Pharma Limited, Benzylpenicillin-Benzathin 1,2 Millionen I.E. und 2,4 Millionen I.E. Pulver zur Herstellung einer Injektionssuspension, EL(26)A/30Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were released with an outdated PIL. Read the full update from MHRA Abo...
By Medicines and Healthcare products Regulatory Agency (MHRA)
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Sicherheitsmitteilungen: 15. bis 19. Juni 2026List of Field Safety Notices from 15 to 19 June 2026. Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vacci...
By Medicines and Healthcare products Regulatory Agency (MHRA)
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
ACE-Hemmer: Beachten Sie den Unterschied zwischen Bradykinin- und Histamin-vermitteltem Angioödem, da sich die Behandlungsstrategien erheblich unterscheidenHealthcare professionals should be aware of the potential for delayed onset of angioedema and the distinction between bradykinin- and histamine-mediated cases, as treatment strategies differ significantly and bradykinin-...
By Medicines and Healthcare products Regulatory Agency (MHRA)
A%2F29/rgba(188%2C%2049%2C%20123%2C%201)/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Rückruf von Arzneimitteln der Klasse 3: Orbit Pharma Limited, Cyclizinlactat 50 mg/ml Injektionslösung, EL(26)A/29Orbit Pharma Limited is recalling a specific batch of Cyclizine Lactate 50 mg/ml Solution for injection as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies identified at the manufacturing sit...
By Medicines and Healthcare products Regulatory Agency (MHRA)
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Feldsicherheitsmitteilungen: 8. - 12. Juni 2026List of Field Safety Notices for 8-12 June 2026 Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vaccines an...
By Medicines and Healthcare products Regulatory Agency (MHRA)